Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks in late surge

Tue, 18th Aug 2009 16:36

A late rally driven by early gains in the US had London back up at session highs, with gains among financial plays easily offsetting a weaker property sector.Investors overcame disappointing US housing starts data that had the blue chip index struggling at session lows mid-afternoon. The annual rate of housing starts fell to 581,000 in July from 587,000 a month earlier. Analysts wanted 598,000.Over here, HSBC strengthened on positive comment from US bank Goldman Sachs. It reckons that HSBC Finance will stop being a major drag on HSBC's earnings from 2010 onwards, earlier than previously expected. Goldman upgraded the shares to 'buy' from 'neutral' and raised its price target from 580p to 820p. It also lifted its target on Standard Chartered.Insurers were also largely better, helped by ongoing speculative interest. Legal & General did well just a week after Resolution launched a recommended bid for Friends Provident.Miners eked out gains as well. Xstrata and BHP Billiton improved, as did cash strapped Rio Tinto which has received a $2.025bn offer for the majority of its Alcan Packaging business. But British Land's results disappointed and cast a shadow over the real estate sector. The owner of the Broadgate development in London's financial district saw the value of its property portfolio fall to £8.18bn in the first quarter, although the pace of decline has slowed markedly. Land Securities and Liberty International were little changed.Elsewhere, a joint venture including support services firm Carillion has won a 'Building Schools for the Future' contract for Durham. The market has given the thumbs up to James Fisher's acquisition of MB Faber, which provides specialist electrical and engineering services to the nuclear and aerospace industries, for up to £5.25m in cash.Car dealer Pendragon reported sharply lower profits in the six months to June 30 as recession-hit motorists held onto their old cars rather than splashing out on new ones. Respiratory inhaler firm Vectura remains "very confident" about prospects with important drug trials due to start later this year and plenty of cash in the bank.Online video services provider Amino Technologies posted an operating loss compared with a profit the same time a year before as challenging economic conditions continued hit the group. Nightclub owner Luminar can breathe a little easier on news that 95.5% of the shares available through an open offer have been taken up and buyers have been found for the remainder.Chip designer Arc International is recommending a £25.2m cash bid from US semiconductor intellectual property firm Virage Logic.The slump in construction activity hit property repair and maintenance company Rok hard in the first half of 2009, but the company is confident of meeting full year expectations, provided market conditions do not deteriorate further.Australian alternative energy developer Ceramic Fuel Cells revealed widening annual losses after it booked significant impairment charges related to losses on financial investments.US navigation equipment specialist Garmin said any offer it makes for marine electronics group Raymarine is likely to be solely in cash. Yesterday, Raymarine confirmed recent press speculation that it is in potential takeover talks with US navigation equipment specialist Garmin and with other parties.Thirdforce said it has received a revised proposal from management buy-out vehicle LearnVantage. The UK E-learning software group said the proposal may or may not lead to an offer for the entire issued and to be issued share capital of the company. FTSE 100 - RisersAmec (AMEC) 744.50p +4.42%Legal & General Group (LGEN) 70.00p +4.17%InterContinental Hotels Group (IHG) 725.50p +3.50%Rexam (REX) 259.30p +2.90%Royal Bank of Scotland Group (RBS) 46.18p +2.87%HSBC Holdings (HSBA) 656.00p +2.82%Compass Group (CPG) 318.70p +2.81%Tullow Oil (TLW) 1,075.00p +2.48%Eurasian Natural Resources (ENRC) 777.00p +2.44%Xstrata (XTA) 758.00p +2.16%FTSE 100 - FallersBritish Land Co (BLND) 483.00p -2.66%Vedanta Resources (VED) 1,690.00p -1.80%Invensys (ISYS) 248.50p -1.62%Petrofac Ltd (PFC) 873.00p -1.02%Sage Group (SGE) 210.10p -0.76%Reed Elsevier (REL) 423.60p -0.54%Home Retail Group (HOME) 296.50p -0.50%Inmarsat (ISAT) 501.50p -0.50%Tesco (TSCO) 363.60p -0.47%Land Securities Group (LAND) 607.50p -0.41%FTSE 250 - RisersFisher (James) & Sons (FSJ) 497.60p +8.15%Dimension Data Holdings (DDT) 59.45p +8.09%Ashtead Group (AHT) 72.40p +5.93%Salamander Energy (SMDR) 207.00p +5.72%Fidessa (FDSA) 1,110.00p +5.71%Inchcape (INCH) 29.63p +4.88%SVG Capital (SVI) 130.10p +4.75%GKN (GKN) 115.10p +4.45%Enterprise Inns (ETI) 154.60p +4.39%Millennium & Copthorne Hotels (MLC) 319.00p +4.25%FTSE 250 - FallersBarratt Developments (BDEV) 218.40p -3.53%Greggs (GRG) 399.80p -2.73%Synergy Healthcare (SYR) 523.00p -2.43%Bodycote (BOY) 155.80p -1.58%Aquarius Platinum Ltd. (AQP) 261.40p -1.54%Helical Bar (HLCL) 351.10p -1.54%DSG International (DSGI) 28.08p -1.51%VT Group (VTG) 483.80p -1.49%Hays (HAS) 99.80p -1.48%TR Property Inv Trust (TRY) 148.00p -1.33%
More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.